1 to 10 of 49 Results
Oct 1, 2026
Minajeva, Ave, 2026, "Original data to article: "Individual Post‑application Activity Test (iPAT) as an Additional Brief Assessment for Evaluating Student Learning in an Integrated Online TBL Setting in Pathology Course"", https://doi.org/10.23673/NWRDJQ, DATADOI, V1, UNF:6:ItbdshEqaK3TtOw2C0Czsg== [fileUNF]
Student gradebook data exported from Moodle for two study years, together with student feedback collected in Year 2. The feedback data are in Estonian; English translations of the questionnaire items are provided in the accompanying research article. |
Plain Text - 8.3 KB -
MD5: 002e65fda3c0924c11e7f2523027f83b
README_iPAT_updated |
Tabular Data - 40.4 KB - 44 Variables, 165 Observations - UNF:6:Tr62ou00FT3JKoCE/3zN0Q==
|
Tabular Data - 40.0 KB - 44 Variables, 179 Observations - UNF:6:CoD+adTlmE9CbuzJX0kAEg==
|
Tabular Data - 13.2 KB - 7 Variables, 77 Observations - UNF:6:bY4sG86Z/hg79LWbn1ULVQ==
|
Jul 3, 2026
Hickey, Miriam A., 2026, "Data for Nanoformulated bisdemethoxycurcumin does not ameliorate pathology or cognitive impairment in 5xFAD transgenic mice", https://doi.org/10.23673/HKYC8R, DATADOI, V1, UNF:6:fnILGjjIuosqDx0MeXewgQ== [fileUNF]
Dementia and dementia-related diseases are a growing societal burden, and they remain largely incurable. Antibody therapies are very costly and their limited accessibility and efficacy underscore the significant continuing importance of small molecule therapeutics. Curcuminoids are of great interest in neurodegenerative diseases, in particular in A... |
Jul 3, 2026 -
Data for Nanoformulated bisdemethoxycurcumin does not ameliorate pathology or cognitive impairment in 5xFAD transgenic mice
Tabular Data - 3.2 KB - 39 Variables, 16 Observations - UNF:6:fnILGjjIuosqDx0MeXewgQ==
|
Jul 3, 2026 -
Data for Nanoformulated bisdemethoxycurcumin does not ameliorate pathology or cognitive impairment in 5xFAD transgenic mice
Plain Text - 13.5 KB -
MD5: 58f5bbe1d7a4f0608f63dfe3290e3c4f
|
Jun 25, 2026
Hickey, Miriam A., 2026, "High-dose levodopa-associated peripheral neuropathy and glial alterations in stressed mice: Protective effects of Vitamin B12", https://doi.org/10.23673/4C6FP0, DATADOI, V1, UNF:6:sy1RAInG23Yi0J3DWcYAEQ== [fileUNF]
Peripheral neuropathy (PN) is a common but understudied non-motor symptom of Parkinson’s disease (PD), and its underlying mechanism remains unclear. Although L-DOPA is the primary treatment for motor symptoms of PD, chronic high-dose exposure may contribute to PN. Using stressed but otherwise healthy mice, we found that high-dose L-DOPA increased c... |
Jun 25, 2026 -
High-dose levodopa-associated peripheral neuropathy and glial alterations in stressed mice: Protective effects of Vitamin B12
Tabular Data - 186 B - 2 Variables, 15 Observations - UNF:6:sy1RAInG23Yi0J3DWcYAEQ==
|
